A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Clinical trial NCT06084936 · RECRUITING
Trial details
- NCT number
- NCT06084936
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-22
- Primary completion
- 2027-08-31
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.